Our long range goal is to understand the role of fetuin in tumorigenesis and metastasis. Fetuin is a approximately 50 kDa serum glycoprotein synthesized primarily by the liver. Its concentration is relatively high in the fetal blood compared to adult blood. Whereas its precise physiological function is not known, it has been shown to be important in bone formation, fetal brain development, and can support the growth of cells in vitro. We have shown that fetuin interacts specifically with matrix metalloproteinases and can activate the zymogen forms of MMP- 2 and MMP-9. These enzymes are important in tumorigenesis and metastasis. The central hypothesis of this grant is that fetuin is able to localize matrix metalloproteinases on the surface of tumor cells and can modulate their activation process. The hypothesis w2ill be tested by three specific aims: 1) Determine the mechanism by which fetuin modulates the activation of matrix metalloproteinases 2) To determine the motifs mechanism by which fetuin modulates the activation of matrix metalloproteinases 2) To determine the motifs in fetuins which are responsible for interaction with matrix metalloproteinases and those responsible for cell surface binding and 3) To employ fetuin knockout mice to determine the role of fetuin in tumorigenesis and metastasis.
In aim #1, immunoprecipitation and confocal microscopy will be used to colocolize MMP-3 and fetuin on the cell surface.
For specific aim #2, Skatchard assays will be used to study the binding of fetuin to squamous and spindle cell carcinomas. Carbohydrate denuding enzymes will be used to assess the contribution of sugar moieties in the binding interactions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA091405-02
Application #
6662112
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-20
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Nichols, Erin E; Richmond, Ann; Daniels, Anthony B (2016) Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma. Semin Ophthalmol 31:304-9
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Ning, Matthew S; Kim, Annette S; Prasad, Nripesh et al. (2014) Characterization of the Merkel Cell Carcinoma miRNome. J Skin Cancer 2014:289548
Seeley, Erin H; Washington, Mary K; Caprioli, Richard M et al. (2013) Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl 7:541-9
M'Koma, Amosy E (2013) Letter to Editor. Adv Enzyme Res 1:77-78
Ochieng, Josiah; Chaudhuri, Gautam (2010) Cystatin superfamily. J Health Care Poor Underserved 21:51-70
Mittal, Mukul K; Myers, Jeremy N; Bailey, Charvann K et al. (2010) Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. Mol Biol Rep 37:1221-7
Zheng, Wei; Cai, Qiuyin; Signorello, Lisa B et al. (2009) Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev 18:2761-4
Daikoku, Takiko; Hirota, Yasushi; Tranguch, Susanne et al. (2008) Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 68:5619-27
Daikoku, Takiko; Tranguch, Susanne; Chakrabarty, Anindita et al. (2007) Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res 67:5285-92

Showing the most recent 10 out of 11 publications